These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
496 related items for PubMed ID: 11884620
1. Protein phosphatase 2A forms a molecular complex with Shc and regulates Shc tyrosine phosphorylation and downstream mitogenic signaling. Ugi S, Imamura T, Ricketts W, Olefsky JM. Mol Cell Biol; 2002 Apr; 22(7):2375-87. PubMed ID: 11884620 [Abstract] [Full Text] [Related]
2. Protein phosphatase 2A negatively regulates insulin's metabolic signaling pathway by inhibiting Akt (protein kinase B) activity in 3T3-L1 adipocytes. Ugi S, Imamura T, Maegawa H, Egawa K, Yoshizaki T, Shi K, Obata T, Ebina Y, Kashiwagi A, Olefsky JM. Mol Cell Biol; 2004 Oct; 24(19):8778-89. PubMed ID: 15367694 [Abstract] [Full Text] [Related]
3. Roles of insulin receptor substrate-1 and Shc on insulin-like growth factor I receptor signaling in early passages of cultured human fibroblasts. Takahashi Y, Tobe K, Kadowaki H, Katsumata D, Fukushima Y, Yazaki Y, Akanuma Y, Kadowaki T. Endocrinology; 1997 Feb; 138(2):741-50. PubMed ID: 9003010 [Abstract] [Full Text] [Related]
4. Increased insulin sensitivity in IGF-I receptor--deficient brown adipocytes. Mur C, Valverde AM, Kahn CR, Benito M. Diabetes; 2002 Mar; 51(3):743-54. PubMed ID: 11872675 [Abstract] [Full Text] [Related]
8. Dual role of SRC homology domain 2-containing inositol phosphatase 2 in the regulation of platelet-derived growth factor and insulin-like growth factor I signaling in rat vascular smooth muscle cells. Sasaoka T, Kikuchi K, Wada T, Sato A, Hori H, Murakami S, Fukui K, Ishihara H, Aota R, Kimura I, Kobayashi M. Endocrinology; 2003 Sep; 144(9):4204-14. PubMed ID: 12933696 [Abstract] [Full Text] [Related]
10. Tyrosine phosphorylation-dependent and -independent role of Shc in the regulation of IGF-1-induced mitogenesis and glycogen synthesis. Sasaoka T, Ishiki M, Wada T, Hori H, Hirai H, Haruta T, Ishihara H, Kobayashi M. Endocrinology; 2001 Dec; 142(12):5226-35. PubMed ID: 11713219 [Abstract] [Full Text] [Related]
12. Comparison of the insulin and insulin-like growth factor 1 mitogenic intracellular signaling pathways. Sasaoka T, Ishiki M, Sawa T, Ishihara H, Takata Y, Imamura T, Usui I, Olefsky JM, Kobayashi M. Endocrinology; 1996 Oct; 137(10):4427-34. PubMed ID: 8828504 [Abstract] [Full Text] [Related]
13. Intracellular signalling pathways of okadaic acid leading to mitogenesis in Rat1 fibroblast overexpressing insulin receptors: okadaic acid regulates Shc phosphorylation by mechanisms independent of insulin. Sawa T, Sasaoka T, Hirai H, Ishihara H, Ishiki M, Wada T, Kobayashi M. Cell Signal; 1999 Nov; 11(11):797-803. PubMed ID: 10617282 [Abstract] [Full Text] [Related]
14. Thyrotropin-releasing hormone stimulates MAP kinase activity in GH3 cells by divergent pathways. Evidence of a role for early tyrosine phosphorylation. Ohmichi M, Sawada T, Kanda Y, Koike K, Hirota K, Miyake A, Saltiel AR. J Biol Chem; 1994 Feb 04; 269(5):3783-8. PubMed ID: 7508919 [Abstract] [Full Text] [Related]
15. Evidence that basal activity, but not transactivation, of the epidermal growth factor receptor tyrosine kinase is required for insulin-like growth factor I-induced activation of extracellular signal-regulated kinase in oral carcinoma cells. Kuribayashi A, Kataoka K, Kurabayashi T, Miura M. Endocrinology; 2004 Nov 04; 145(11):4976-84. PubMed ID: 15271882 [Abstract] [Full Text] [Related]
16. Involvement of Raf-1 kinase and protein kinase C zeta in insulin-like growth factor I-induced brown adipocyte mitogenic signaling cascades: inhibition by cyclic adenosine 3',5'-monophosphate. Valverde AM, Teruel T, Lorenzo M, Benito M. Endocrinology; 1996 Sep 04; 137(9):3832-41. PubMed ID: 8756554 [Abstract] [Full Text] [Related]
17. Insulin receptor substrate 2 and Shc play different roles in insulin-like growth factor I signaling. Kim B, Cheng HL, Margolis B, Feldman EL. J Biol Chem; 1998 Dec 18; 273(51):34543-50. PubMed ID: 9852124 [Abstract] [Full Text] [Related]
18. Shc phosphotyrosine-binding domain dominantly interacts with epidermal growth factor receptors and mediates Ras activation in intact cells. Sakaguchi K, Okabayashi Y, Kido Y, Kimura S, Matsumura Y, Inushima K, Kasuga M. Mol Endocrinol; 1998 Apr 18; 12(4):536-43. PubMed ID: 9544989 [Abstract] [Full Text] [Related]